Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Polivy

PharmaCompass

01

Brand Name : Polivy

Polatuzumab Vedotin

arrow
American Pharma Summit
Not Confirmed

Brand Name : Polivy

arrow
American Pharma Summit
Not Confirmed

Polatuzumab Vedotin

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 188

2019 Revenue in Millions : 57

Growth (%) : 231

blank

02

Brand Name : Polivy

Polatuzumab Vedotin

arrow
American Pharma Summit
Not Confirmed

Brand Name : Polivy

arrow
American Pharma Summit
Not Confirmed

Polatuzumab Vedotin

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 266

2020 Revenue in Millions : 179

Growth (%) : 46

blank

03

Brand Name : Polivy

Polatuzumab Vedotin

arrow
American Pharma Summit
Not Confirmed

Brand Name : Polivy

arrow
American Pharma Summit
Not Confirmed

Polatuzumab Vedotin

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 478

2021 Revenue in Millions : 266

Growth (%) : 80

blank

04

Brand Name : Polivy

Polatuzumab Vedotin-piiq

arrow
American Pharma Summit
Not Confirmed